OPEN END TURBO LONG - MERCK & CO. Stock

Certificat

DE000MD9LHH8

Real-time Bid/Ask 03:45:57 2024-07-05 am EDT
2.29 EUR / 2.34 EUR +2.89% Intraday chart for OPEN END TURBO LONG - MERCK & CO.
Current month-10.71%
1 month-14.45%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-04 2.25 -2.60%
24-07-03 2.31 -8.33%
24-07-02 2.52 -1.95%
24-07-01 2.57 +1.98%
24-06-28 2.52 -7.69%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 03:52 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD9LHH
ISINDE000MD9LHH8
Date issued 2022-10-20
Strike 100.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.15
Lowest since issue 0.37
Spread 0.05
Spread %2.14%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus